【摘要】 目的 观察美罗培南治疗慢性盆腔炎的临床疗效和安全性。方法 将90例盆腔炎患者随机分为1.5 g治疗组45例(A组)和头孢米诺3.0 g对照组45例(B组)，每天分3次使用，疗程均为7~14 d。比较两组临床疗效、细菌学改变及不良反应情况。结果 A、B组临床有效率分别为97.78%、95.56%，二者比较差异无统计学意义(P>0.05)。结论 美罗培南治疗慢性盆腔炎安全、有效。

    【关键词】 美罗培南；头孢米诺；慢性盆腔炎

    Efficacy and safety meropenrm in patients with chronic pelvic inflammability disease

    QI Zhi-gao,GU Xiang-fu,ZHANG Shi-yun.The Affiliated Hospital of Dali College,DaliYunnan Province 671000,China

    【Abstract】 Objective To evaluate the efficacy and safety of meropenem in the treatment of patients with chronic pelvic inflammability disease.Methods A total of 90 cases were randomly divided into study group and control group(each group have 45 patients),study group(group A)were treated by meropenem 1.5 g,control group(group B)were treated by cefminox 3.0 g,3 time per day,all patients treated 7-14 days as a course.The clinical efficacy,the bacterial clearance rates and adverse drug reaction of 2 groups were compared.Results The clinical efficacy rate of group A and B were 97.78%and 95.56%respectively,were no statistical differences between 2 groups(P>0.05).Conclusion Meropenem is an effective and safe agent for treatment of patients with chroriic pelvic inflammability disease. ......